Fundraising FoxLilly Asia Ventures — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
Fortis Therapeuticsfortistx.comSep 2016 · $18M✓ verified
Fortis Therapeutics develops therapeutic treatments based on technology licensed from UCSF, with a focus on oncology and other disease areas.
BiotechHealthtechMedical DevicesSan Diego, US
Marc Nasoff(Chief Scientific Officer)
BoardJay B. Lichter(Ph.D.)in
Co-investorsVivo CapitalAvalon BioVenturesOUP (Osage University Partners)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.